Showing 61 - 80 results of 1,762 for search '(( 10 ((peer decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 100 due decrease ))*', query time: 0.24s Refine Results
  1. 61
  2. 62

    A Modification to Enhance the Survival of the Island FDMA Flap by Adding a Skin Bridge by Al Lahham, Salim

    Published 2021
    “…Distal necrosis of the patients in this study patients was compared with that in a control of 10 patients in whom we did the conventional FDMA flap. …”
    Get full text
    Get full text
    Get full text
  3. 63
  4. 64

    The Cardiovascular Benefits of Empagliflozin, A Sodium Glucose Cotransporter Inhibitor: Is NHE1 a Viable Target? by Al-Shamasi, Al-Anood

    Published 2020
    “…Empagliflozin (EMPA), an SGLT2 inhibitor (with a low affinity for SGLT1) has attracted much attention due to a recent clinical trial, the Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (EMPA-REG OUTCOME). …”
    Get full text
    Get full text
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80

    Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial by El Hajj, Maguy

    Published 2015
    “…Discussion: If proven to be effective, this smoking cessation program will be considered as a model that Qatar and the region can apply to decrease the smoking burden. …”
    Get full text
    Get full text